Loading...

Pereira, Renata C

Title(s)Associate Adjunct Professor, Pediatrics
SchoolPeds - Nephrology
Phone3109833084
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Laster M, Pereira RC, Salusky IB. Unraveling the osteocyte in CKD-MBD post-renal transplantation. Kidney Int. 2019 Nov; 96(5):1059-1061. PMID: 31648693.
      View in: PubMed
    2. Hanudel MR, Salusky IB, Pereira RC, Wang W, You Z, Nowak KL, Brosnahan GM, Torres VE, Chapman AB, Perrone RD, Steinman TI, Bae KT, Gitomer BY, Chonchol MB. Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients. Kidney Int Rep. 2019 Dec; 4(12):1742-1748. PMID: 31844811.
      View in: PubMed
    3. Pereira RC, Salusky IB, Bowen RE, Freymiller EG, Wesseling-Perry K. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone. Bone. 2019 Oct; 127:626-634. PMID: 31377240.
      View in: PubMed
    4. Laster M, Pereira RC, Salusky IB. Racial differences in bone histomorphometry in children and young adults treated with dialysis. Bone. 2019 Oct; 127:114-119. PMID: 31181383.
      View in: PubMed
    5. Pereira RC, Salusky IB, Roschger P, Klaushofer K, Yadin O, Freymiller EG, Bowen R, Delany AM, Fratzl-Zelman N, Wesseling-Perry K. Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy. Kidney Int. 2018 11; 94(5):1002-1012. PMID: 30348285.
      View in: PubMed
    6. Florenzano P, Ferreira C, Nesterova G, Roberts MS, Tella SH, de Castro LF, Brown SM, Whitaker A, Pereira RC, Bulas D, Gafni RI, Salusky IB, Gahl WA, Collins MT. Skeletal Consequences of Nephropathic Cystinosis. J Bone Miner Res. 2018 10; 33(10):1870-1880. PMID: 29905968.
      View in: PubMed
    7. Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K. Erratum to "Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease" [Bone, 45(6) (2009) 1161-1168]. Bone. 2018 03; 108:210-211. PMID: 29290423.
      View in: PubMed
    8. Wesseling-Perry K, Mäkitie RE, Välimäki VV, Laine T, Laine CM, Välimäki MJ, Pereira RC, Mäkitie O. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3. J Clin Endocrinol Metab. 2017 07 01; 102(7):2340-2348. PMID: 28379384.
      View in: PubMed
    9. Buser Z, Drapeau S, Stappenbeck F, Pereira RC, Parhami F, Wang JC. Effect of Oxy133, an osteogenic oxysterol, on new bone formation in rat two-level posterolateral fusion model. Eur Spine J. 2017 11; 26(11):2763-2772. PMID: 28547574.
      View in: PubMed
    10. Fratzl-Zelman N, Valta H, Pereira RC, Misof BM, Roschger P, Jalanko H, Wesseling-Perry K, Klaushofer K, Mäkitie O. Abnormally High and Heterogeneous Bone Matrix Mineralization After Childhood Solid Organ Transplantation: A Complex Pathology of Low Bone Turnover and Local Defects in Mineralization. J Bone Miner Res. 2017 May; 32(5):1116-1125. PMID: 28214296.
      View in: PubMed
    11. Chun RF, Hernandez I, Pereira R, Swinkles L, Huijs T, Zhou R, Liu NQ, Shieh A, Guemes M, Mallya SM, Adams JS, Hewison M. Differential Responses to Vitamin D2 and Vitamin D3 Are Associated With Variations in Free 25-Hydroxyvitamin D. Endocrinology. 2016 09; 157(9):3420-30. PMID: 27399876.
      View in: PubMed
    12. Pereira RC, Andersen TL, Friedman PA, Tumber N, Salusky IB, Wesseling-Perry K. Correction: Bone Canopies in Pediatric Renal Osteodystrophy. PLoS One. 2016; 11(5):e0155663. PMID: 27167735.
      View in: PubMed
    13. Pereira RC, Andersen TL, Friedman PA, Tumber N, Salusky IB, Wesseling-Perry K. Bone Canopies in Pediatric Renal Osteodystrophy. PLoS One. 2016; 11(4):e0152871. PMID: 27045269.
      View in: PubMed
    14. Pereira RC, Bischoff DS, Yamaguchi D, Salusky IB, Wesseling-Perry K. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry. Clin J Am Soc Nephrol. 2016 Mar 07; 11(3):481-7. PMID: 26712809.
      View in: PubMed
    15. Pereira RC, Valta H, Tumber N, Salusky IB, Jalanko H, Mäkitie O, Wesseling Perry K. Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation. PLoS One. 2015; 10(9):e0138156. PMID: 26390291.
      View in: PubMed
    16. Dole NS, Kapinas K, Kessler CB, Yee SP, Adams DJ, Pereira RC, Delany AM. A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433. J Bone Miner Res. 2015 Apr; 30(4):723-32. PMID: 25262637.
      View in: PubMed
    17. Pereira RC, Jüppner H, Gales B, Salusky IB, Wesseling-Perry K. Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients. PLoS One. 2015; 10(3):e0120856. PMID: 25774916.
      View in: PubMed
    18. Scott TP, Phan KH, Tian H, Suzuki A, Montgomery SR, Johnson JS, Atti E, Tetratis S, Pereira RC, Wang JC, Daubs MD, Stappenbeck F, Parhami F. Comparison of a novel oxysterol molecule and rhBMP2 fusion rates in a rabbit posterolateral lumbar spine model. Spine J. 2015 Apr 01; 15(4):733-42. PMID: 25450659.
      View in: PubMed
    19. Pereira RC, Delany AM, Khouzam NM, Bowen RE, Freymiller EG, Salusky IB, Wesseling-Perry K. Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo. Kidney Int. 2015 Mar; 87(3):593-601. PMID: 25354236.
      View in: PubMed
    20. Carvalho CG, Pereira RC, Gales B, Salusky IB, Wesseling-Perry K. Cortical and trabecular bone in pediatric end-stage kidney disease. Pediatr Nephrol. 2015 Mar; 30(3):497-502. PMID: 25185885.
      View in: PubMed
    21. Montgomery SR, Nargizyan T, Meliton V, Nachtergaele S, Rohatgi R, Stappenbeck F, Jung ME, Johnson JS, Aghdasi B, Tian H, Weintraub G, Inoue H, Atti E, Tetradis S, Pereira RC, Hokugo A, Alobaidaan R, Tan Y, Hahn TJ, Wang JC, Parhami F. A novel osteogenic oxysterol compound for therapeutic development to promote bone growth: activation of hedgehog signaling and osteogenesis through smoothened binding. J Bone Miner Res. 2014 Aug; 29(8):1872-85. PMID: 24591126.
      View in: PubMed
    22. van Venrooij NA, Pereira RC, Tintut Y, Fishbein MC, Tumber N, Demer LL, Salusky IB, Wesseling-Perry K. FGF23 protein expression in coronary arteries is associated with impaired kidney function. Nephrol Dial Transplant. 2014 Aug; 29(8):1525-32. PMID: 24459137.
      View in: PubMed
    23. Wesseling-Perry K, Pereira RC, Tsai E, Ettenger R, Jüppner H, Salusky IB. FGF23 and mineral metabolism in the early post-renal transplantation period. Pediatr Nephrol. 2013 Nov; 28(11):2207-15. PMID: 23852336.
      View in: PubMed
    24. Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int. 2013 Oct; 84(4):776-85. PMID: 23657144.
      View in: PubMed
    25. Bacchetta J, Wesseling-Perry K, Kuizon B, Pereira RC, Gales B, Wang HJ, Elashoff R, Salusky IB. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial. Clin J Am Soc Nephrol. 2013 May; 8(5):824-32. PMID: 23559676.
      View in: PubMed
    26. Bacchetta J, Wesseling-Perry K, Gilsanz V, Gales B, Pereira RC, Salusky IB. Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography. Pediatr Rheumatol Online J. 2013; 11:6. PMID: 23418950.
      View in: PubMed
    27. Leaf DE, Pereira RC, Bazari H, Jüppner H. Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma. J Clin Endocrinol Metab. 2013 Mar; 98(3):887-91. PMID: 23393166.
      View in: PubMed
    28. Zhang MY, Ranch D, Pereira RC, Armbrecht HJ, Portale AA, Perwad F. Chronic inhibition of ERK1/2 signaling improves disordered bone and mineral metabolism in hypophosphatemic (Hyp) mice. Endocrinology. 2012 Apr; 153(4):1806-16. PMID: 22334725.
      View in: PubMed
    29. Wesseling-Perry K, Pereira RC, Tseng CH, Elashoff R, Zaritsky JJ, Yadin O, Sahney S, Gales B, Jüppner H, Salusky IB. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2012 Jan; 7(1):146-52. PMID: 22052943.
      View in: PubMed
    30. Johnson JS, Meliton V, Kim WK, Lee KB, Wang JC, Nguyen K, Yoo D, Jung ME, Atti E, Tetradis S, Pereira RC, Magyar C, Nargizyan T, Hahn TJ, Farouz F, Thies S, Parhami F. Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo. J Cell Biochem. 2011 Jun; 112(6):1673-84. PMID: 21503957.
      View in: PubMed
    31. Mäkitie O, Pereira RC, Kaitila I, Turan S, Bastepe M, Laine T, Kröger H, Cole WG, Jüppner H. Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation. J Bone Miner Res. 2010 Oct; 25(10):2165-74. PMID: 20499351.
      View in: PubMed
    32. Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang HJ, Elashoff R, Jüppner H, Salusky IB. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int. 2011 Jan; 79(1):112-9. PMID: 20861820.
      View in: PubMed
    33. Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB. Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1860-6. PMID: 20634327.
      View in: PubMed
    34. Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone. 2009 Dec; 45(6):1161-8. PMID: 19679205.
      View in: PubMed
    35. Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Jüppner H, Salusky IB. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab. 2009 Feb; 94(2):511-7. PMID: 19050056.
      View in: PubMed
    36. Hernandez JD, Wesseling K, Pereira R, Gales B, Harrison R, Salusky IB. Technical approach to iliac crest biopsy. Clin J Am Soc Nephrol. 2008 Nov; 3 Suppl 3:S164-9. PMID: 18988702.
      View in: PubMed
    37. Pereira RC, Stadmeyer LE, Smith DL, Rydziel S, Canalis E. CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia. Bone. 2007 Mar; 40(3):619-26. PMID: 17095306.
      View in: PubMed
    38. Pereira RC, Stadmeyer L, Marciniak SJ, Ron D, Canalis E. C/EBP homologous protein is necessary for normal osteoblastic function. J Cell Biochem. 2006 Feb 15; 97(3):633-40. PMID: 16220546.
      View in: PubMed
    39. Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN, Canalis E. Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology. 2005 Feb; 146(2):655-65. PMID: 15539560.
      View in: PubMed
    40. Pereira RC, Delany AM, Canalis E. CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology. 2004 Apr; 145(4):1952-60. PMID: 14684614.
      View in: PubMed
    41. Canalis E, Pereira RC, Delany AM. Effects of glucocorticoids on the skeleton. J Pediatr Endocrinol Metab. 2002 Dec; 15 Suppl 5:1341-5. PMID: 12510988.
      View in: PubMed